CDXS
Codexis, Inc.$2.78+0.13 (+4.91%)Prev Close$2.65·MCap$240.8M·P/E—·Vol1.10M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
12
$91.8K
◆
Net Activity
Net Seller
$91.8K
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Codexis, Inc. (CDXS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 12 insider sales totaling $91.8K. The most recent insider transaction was by Lutz Stefan (officer: Chief Scientific Officer), who sold $6.6K worth of shares on Feb 25, 2026. Codexis, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $240.8M.
CDXS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Lutz Stefan | officer: Chief Scientific Officer | Sell | 5,862 | $1.13 | $6.6K | 130,421 |
| Feb 9, 2026 | Erbez Georgia | officer: See Remarks | Sell | 3,826 | $1.31 | $5.0K | 66,810 |
| Feb 9, 2026 | Lutz Stefan | officer: Chief Scientific Officer | Sell | 2,492 | $1.31 | $3.3K | 136,283 |
| Feb 9, 2026 | MOORE ALISON | director, officer: President and CEO | Sell | 3,826 | $1.31 | $5.0K | 250,506 |
| Feb 6, 2026 | Erbez Georgia | See Remarks | Sell | 3,826 | $1.31 | $5.0K | 0 |
| Feb 6, 2026 | Lutz Stefan | Chief Scientific Officer | Sell | 2,492 | $1.31 | $3.3K | 0 |
| Jan 8, 2026 | Lutz Stefan | officer: CSO | Sell | 4,685 | $1.70 | $7.9K | 138,775 |
| Jan 7, 2026 | Lutz Stefan | CSO | Sell | 4,685 | $1.70 | $7.9K | 0 |
| Nov 21, 2025 | WOLF DENNIS P | Director | Sell | 8,952 | $1.56 | $14.0K | 0 |
| Nov 11, 2025 | De Vre Raymond | Director | Sell | 1,413 | $1.74 | $2.5K | 0 |
| Oct 13, 2025 | Erbez Georgia | Chief Financial Officer | Sell | 6,239 | $2.51 | $15.6K | 0 |
| Oct 13, 2025 | MOORE ALISON | Chief Technical Officer | Sell | 6,239 | $2.51 | $15.6K | 0 |
| Nov 15, 2023 | Dorgan Byron L | Director | Sell | 20,000 | $2.11 | $42.2K | 0 |
| Sep 11, 2023 | Norrett Kevin | Chief Operating Officer | Buy | 9,000 | $1.72 | $15.5K | 0 |
| Sep 8, 2023 | DILLY STEPHEN GEORGE | See Remarks | Buy | 58,479 | $1.73 | $101.0K | 0 |
| Sep 8, 2023 | Fitzgerald Margaret Nell | See Remarks | Buy | 11,834 | $1.70 | $20.1K | 0 |
| Sep 8, 2023 | Ryali Sriram | Chief Financial Officer | Buy | 11,650 | $1.70 | $19.9K | 0 |
| Apr 17, 2023 | NICOLS JOHN J | Director | Sell | 71,428 | $4.19 | $299.3K | 0 |
| Mar 15, 2023 | NICOLS JOHN J | Director | Sell | 71,428 | $4.10 | $292.8K | 0 |
| Feb 23, 2023 | NICOLS JOHN J | Director | Sell | 75,499 | $5.11 | $385.9K | 0 |
| Feb 8, 2023 | DILLY STEPHEN GEORGE | See Remarks | Sell | 55,075 | $4.58 | $252.2K | 0 |
| Feb 8, 2023 | Fitzgerald Margaret Nell | See remarks | Sell | 15,686 | $4.58 | $71.8K | 0 |
| Feb 8, 2023 | Norrett Kevin | Chief Operating Officer | Sell | 16,854 | $4.58 | $77.2K | 0 |
| Feb 7, 2023 | TAYLOR DEAN ROSS JR | Insider | Sell | 1,224 | $6.51 | $8.0K | 0 |
| Jan 23, 2023 | NICOLS JOHN J | Director | Sell | 75,499 | $6.50 | $490.9K | 0 |
| Dec 9, 2022 | NICOLS JOHN J | Director | Sell | 75,499 | $5.67 | $427.8K | 0 |
| Nov 15, 2022 | NICOLS JOHN J | Director | Sell | 75,500 | $6.59 | $497.6K | 0 |
| Oct 27, 2022 | NICOLS JOHN J | Director | Sell | 75,502 | $5.61 | $423.6K | 0 |
| Oct 5, 2022 | NICOLS JOHN J | Director | Sell | 75,503 | $6.02 | $454.2K | 0 |
| Aug 12, 2022 | NICOLS JOHN J | Director | Sell | 77,500 | $8.70 | $674.4K | 0 |
| May 11, 2022 | NICOLS JOHN J | President and CEO | Sell | 77,000 | $10.31 | $793.9K | 0 |
| Mar 23, 2022 | WOLF DENNIS P | Director | Sell | 4,000 | $20.49 | $81.9K | 0 |
| Mar 15, 2022 | Yang Patrick Y | Director | Sell | 8,000 | $16.79 | $134.3K | 0 |
| Mar 9, 2022 | NICOLS JOHN J | President and CEO | Sell | 77,000 | $19.11 | $1.47M | 0 |
| Mar 5, 2022 | TAYLOR DEAN ROSS JR | SVP, Chief Financial Officer | Sell | 4,427 | $19.30 | $85.4K | 0 |
| Dec 20, 2021 | WOLF DENNIS P | Director | Sell | 5,000 | $28.83 | $144.2K | 0 |
| Dec 13, 2021 | Yang Patrick Y | Director | Sell | 8,000 | $31.60 | $252.8K | 0 |
| Nov 10, 2021 | NICOLS JOHN J | President and CEO | Sell | 73,500 | $39.32 | $2.89M | 0 |
| Oct 18, 2021 | Dorgan Byron L | Director | Sell | 20,000 | $27.94 | $558.9K | 0 |
| Oct 15, 2021 | WOLF DENNIS P | Director | Sell | 6,000 | $28.30 | $169.8K | 0 |
| Aug 12, 2021 | NICOLS JOHN J | President and CEO | Sell | 70,000 | $24.15 | $1.69M | 0 |
| Aug 10, 2021 | KELLEY BERNARD J | Director | Sell | 20,000 | $25.84 | $516.8K | 0 |
| Jun 15, 2021 | Yang Patrick Y | Director | Sell | 20,000 | $20.31 | $406.2K | 0 |
| May 17, 2021 | NICOLS JOHN J | President and CEO | Sell | 70,385 | $18.45 | $1.30M | 0 |
| Apr 21, 2021 | KELLEY BERNARD J | Director | Sell | 2,500 | $22.64 | $56.6K | 0 |
| Apr 5, 2021 | Yang Patrick Y | Director | Sell | 20,000 | $24.71 | $494.3K | 0 |
| Mar 25, 2021 | WOLF DENNIS P | Director | Sell | 10,000 | $20.44 | $204.4K | 0 |
| Mar 8, 2021 | KELLEY BERNARD J | Director | Sell | 20,000 | $18.72 | $374.4K | 0 |
| Mar 5, 2021 | TAYLOR DEAN ROSS JR | SVP, Chief Financial Officer | Sell | 2,419 | $19.51 | $47.2K | 0 |
CDXS Insider Buying Activity
The following table shows recent insider purchases of Codexis, Inc. (CDXS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Norrett Kevin | Chief Operating Officer | Buy | 9,000 | $1.72 | $15.5K | 0 |
| Sep 8, 2023 | DILLY STEPHEN GEORGE | See Remarks | Buy | 58,479 | $1.73 | $101.0K | 0 |
| Sep 8, 2023 | Fitzgerald Margaret Nell | See Remarks | Buy | 11,834 | $1.70 | $20.1K | 0 |
| Sep 8, 2023 | Ryali Sriram | Chief Financial Officer | Buy | 11,650 | $1.70 | $19.9K | 0 |
CDXS Insider Selling Activity
The following table shows recent insider sales of Codexis, Inc. (CDXS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Lutz Stefan | officer: Chief Scientific Officer | Sell | 5,862 | $1.13 | $6.6K | 130,421 |
| Feb 9, 2026 | Erbez Georgia | officer: See Remarks | Sell | 3,826 | $1.31 | $5.0K | 66,810 |
| Feb 9, 2026 | Lutz Stefan | officer: Chief Scientific Officer | Sell | 2,492 | $1.31 | $3.3K | 136,283 |
| Feb 9, 2026 | MOORE ALISON | director, officer: President and CEO | Sell | 3,826 | $1.31 | $5.0K | 250,506 |
| Feb 6, 2026 | Erbez Georgia | See Remarks | Sell | 3,826 | $1.31 | $5.0K | 0 |
| Feb 6, 2026 | Lutz Stefan | Chief Scientific Officer | Sell | 2,492 | $1.31 | $3.3K | 0 |
| Jan 8, 2026 | Lutz Stefan | officer: CSO | Sell | 4,685 | $1.70 | $7.9K | 138,775 |
| Jan 7, 2026 | Lutz Stefan | CSO | Sell | 4,685 | $1.70 | $7.9K | 0 |
| Nov 21, 2025 | WOLF DENNIS P | Director | Sell | 8,952 | $1.56 | $14.0K | 0 |
| Nov 11, 2025 | De Vre Raymond | Director | Sell | 1,413 | $1.74 | $2.5K | 0 |
| Oct 13, 2025 | Erbez Georgia | Chief Financial Officer | Sell | 6,239 | $2.51 | $15.6K | 0 |
| Oct 13, 2025 | MOORE ALISON | Chief Technical Officer | Sell | 6,239 | $2.51 | $15.6K | 0 |
| Nov 15, 2023 | Dorgan Byron L | Director | Sell | 20,000 | $2.11 | $42.2K | 0 |
| Apr 17, 2023 | NICOLS JOHN J | Director | Sell | 71,428 | $4.19 | $299.3K | 0 |
| Mar 15, 2023 | NICOLS JOHN J | Director | Sell | 71,428 | $4.10 | $292.8K | 0 |
| Feb 23, 2023 | NICOLS JOHN J | Director | Sell | 75,499 | $5.11 | $385.9K | 0 |
| Feb 8, 2023 | DILLY STEPHEN GEORGE | See Remarks | Sell | 55,075 | $4.58 | $252.2K | 0 |
| Feb 8, 2023 | Fitzgerald Margaret Nell | See remarks | Sell | 15,686 | $4.58 | $71.8K | 0 |
| Feb 8, 2023 | Norrett Kevin | Chief Operating Officer | Sell | 16,854 | $4.58 | $77.2K | 0 |
| Feb 7, 2023 | TAYLOR DEAN ROSS JR | Insider | Sell | 1,224 | $6.51 | $8.0K | 0 |
| Jan 23, 2023 | NICOLS JOHN J | Director | Sell | 75,499 | $6.50 | $490.9K | 0 |
| Dec 9, 2022 | NICOLS JOHN J | Director | Sell | 75,499 | $5.67 | $427.8K | 0 |
| Nov 15, 2022 | NICOLS JOHN J | Director | Sell | 75,500 | $6.59 | $497.6K | 0 |
| Oct 27, 2022 | NICOLS JOHN J | Director | Sell | 75,502 | $5.61 | $423.6K | 0 |
| Oct 5, 2022 | NICOLS JOHN J | Director | Sell | 75,503 | $6.02 | $454.2K | 0 |
| Aug 12, 2022 | NICOLS JOHN J | Director | Sell | 77,500 | $8.70 | $674.4K | 0 |
| May 11, 2022 | NICOLS JOHN J | President and CEO | Sell | 77,000 | $10.31 | $793.9K | 0 |
| Mar 23, 2022 | WOLF DENNIS P | Director | Sell | 4,000 | $20.49 | $81.9K | 0 |
| Mar 15, 2022 | Yang Patrick Y | Director | Sell | 8,000 | $16.79 | $134.3K | 0 |
| Mar 9, 2022 | NICOLS JOHN J | President and CEO | Sell | 77,000 | $19.11 | $1.47M | 0 |
| Mar 5, 2022 | TAYLOR DEAN ROSS JR | SVP, Chief Financial Officer | Sell | 4,427 | $19.30 | $85.4K | 0 |
| Dec 20, 2021 | WOLF DENNIS P | Director | Sell | 5,000 | $28.83 | $144.2K | 0 |
| Dec 13, 2021 | Yang Patrick Y | Director | Sell | 8,000 | $31.60 | $252.8K | 0 |
| Nov 10, 2021 | NICOLS JOHN J | President and CEO | Sell | 73,500 | $39.32 | $2.89M | 0 |
| Oct 18, 2021 | Dorgan Byron L | Director | Sell | 20,000 | $27.94 | $558.9K | 0 |
| Oct 15, 2021 | WOLF DENNIS P | Director | Sell | 6,000 | $28.30 | $169.8K | 0 |
| Aug 12, 2021 | NICOLS JOHN J | President and CEO | Sell | 70,000 | $24.15 | $1.69M | 0 |
| Aug 10, 2021 | KELLEY BERNARD J | Director | Sell | 20,000 | $25.84 | $516.8K | 0 |
| Jun 15, 2021 | Yang Patrick Y | Director | Sell | 20,000 | $20.31 | $406.2K | 0 |
| May 17, 2021 | NICOLS JOHN J | President and CEO | Sell | 70,385 | $18.45 | $1.30M | 0 |
| Apr 21, 2021 | KELLEY BERNARD J | Director | Sell | 2,500 | $22.64 | $56.6K | 0 |
| Apr 5, 2021 | Yang Patrick Y | Director | Sell | 20,000 | $24.71 | $494.3K | 0 |
| Mar 25, 2021 | WOLF DENNIS P | Director | Sell | 10,000 | $20.44 | $204.4K | 0 |
| Mar 8, 2021 | KELLEY BERNARD J | Director | Sell | 20,000 | $18.72 | $374.4K | 0 |
| Mar 5, 2021 | TAYLOR DEAN ROSS JR | SVP, Chief Financial Officer | Sell | 2,419 | $19.51 | $47.2K | 0 |
CDXS Insiders
Similar Stocks to CDXS
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B